These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 12241641)

  • 1. Anti-inflammatory effect of cerivastatin in vascular injury independent of serum cholesterol and blood pressure lowering effects in mouse model.
    Chen X; Li Z; Li J
    Chin J Traumatol; 2002 Oct; 5(5):294-8. PubMed ID: 12241641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olmesartan inhibits the expression of monocyte chemoattractant protein-1 and tumor necrosis factor-alpha and improves vascular remodeling after vascular injury in mouse.
    Li Z; Chen XD; Ni SK; Li JW; Lin MS
    Chin J Traumatol; 2004 Feb; 7(1):56-61. PubMed ID: 14728822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMG-CoA reductase inhibition reduces the proinflammatory activation of human vascular smooth muscle cells by the terminal complement factor C5b-9.
    Viedt C; Shen W; Fei J; Kamimura M; Hänsch GM; Katus HA; Kreuzer J
    Basic Res Cardiol; 2003 Nov; 98(6):353-61. PubMed ID: 14556080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins inhibit in vitro calcification of human vascular smooth muscle cells induced by inflammatory mediators.
    Kizu A; Shioi A; Jono S; Koyama H; Okuno Y; Nishizawa Y
    J Cell Biochem; 2004 Nov; 93(5):1011-9. PubMed ID: 15389884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure- and cholesterol-lowering effects.
    Park JK; Müller DN; Mervaala EM; Dechend R; Fiebeler A; Schmidt F; Bieringer M; Schäfer O; Lindschau C; Schneider W; Ganten D; Luft FC; Haller H
    Kidney Int; 2000 Oct; 58(4):1420-30. PubMed ID: 11012877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory stress induces statin resistance by disrupting 3-hydroxy-3-methylglutaryl-CoA reductase feedback regulation.
    Chen Y; Ku H; Zhao L; Wheeler DC; Li LC; Li Q; Varghese Z; Moorhead JF; Powis SH; Huang A; Ruan XZ
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):365-76. PubMed ID: 24233489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local statin therapy differentially interferes with smooth muscle and endothelial cell proliferation and reduces neointima on a drug-eluting stent platform.
    Jaschke B; Michaelis C; Milz S; Vogeser M; Mund T; Hengst L; Kastrati A; Schömig A; Wessely R
    Cardiovasc Res; 2005 Dec; 68(3):483-92. PubMed ID: 16111664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephroprotective effect of the HMG-CoA-reductase inhibitor cerivastatin in a mouse model of progressive renal fibrosis in Alport syndrome.
    Koepke ML; Weber M; Schulze-Lohoff E; Beirowski B; Segerer S; Gross O
    Nephrol Dial Transplant; 2007 Apr; 22(4):1062-9. PubMed ID: 17287218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerivastatin improves survival of mice with lipopolysaccharide-induced sepsis.
    Ando H; Takamura T; Ota T; Nagai Y; Kobayashi K
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1043-6. PubMed ID: 10945857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin (cerivastatin) protects mice against sepsis-related death via reduced proinflammatory cytokines and enhanced bacterial clearance.
    Chaudhry MZ; Wang JH; Blankson S; Redmond HP
    Surg Infect (Larchmt); 2008 Apr; 9(2):183-94. PubMed ID: 18426351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central role of endogenous Toll-like receptor-2 activation in regulating inflammation, reactive oxygen species production, and subsequent neointimal formation after vascular injury.
    Shishido T; Nozaki N; Takahashi H; Arimoto T; Niizeki T; Koyama Y; Abe J; Takeishi Y; Kubota I
    Biochem Biophys Res Commun; 2006 Jul; 345(4):1446-53. PubMed ID: 16730663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atorvastatin inhibits myocardin expression in vascular smooth muscle cells.
    Li J; Jiang J; Yin H; Wang L; Tian R; Li H; Wang Z; Li D; Wang Y; Gui Y; Walsh MP; Zheng XL
    Hypertension; 2012 Jul; 60(1):145-53. PubMed ID: 22615115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial nitric oxide synthase is essential for the HMG-CoA reductase inhibitor cerivastatin to promote collateral growth in response to ischemia.
    Sata M; Nishimatsu H; Suzuki E; Sugiura S; Yoshizumi M; Ouchi Y; Hirata Y; Nagai R
    FASEB J; 2001 Nov; 15(13):2530-2. PubMed ID: 11641268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cerivastatin on human arterial smooth muscle cell proliferation and migration in transfilter cocultures.
    Axel DI; Riessen R; Runge H; Viebahn R; Karsch KR
    J Cardiovasc Pharmacol; 2000 Apr; 35(4):619-29. PubMed ID: 10774794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cerivastatin sodium, a new inhibitor of HMG-CoA reductase, on plasma lipid levels, progression of atherosclerosis, and the lesional composition in the plaques of WHHL rabbits.
    Shiomi M; Ito T
    Br J Pharmacol; 1999 Feb; 126(4):961-8. PubMed ID: 10193776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct in vivo evidence of a vascular statin: a single dose of cerivastatin rapidly increases vascular endothelial responsiveness in healthy normocholesterolaemic subjects.
    Omori H; Nagashima H; Tsurumi Y; Takagi A; Ishizuka N; Hagiwara N; Kawana M; Kasanuki H
    Br J Clin Pharmacol; 2002 Oct; 54(4):395-9. PubMed ID: 12392587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of neointimal hyperplasia in the rat carotid artery injury model by a HMGB1 inhibitor.
    Chen J; Zhang J; Xu L; Xu C; Chen S; Yang J; Jiang H
    Atherosclerosis; 2012 Oct; 224(2):332-9. PubMed ID: 22857898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aging exacerbates neointimal formation, and increases proliferation and reduces susceptibility to apoptosis of vascular smooth muscle cells in mice.
    Vazquez-Padron RI; Lasko D; Li S; Louis L; Pestana IA; Pang M; Liotta C; Fornoni A; Aitouche A; Pham SM
    J Vasc Surg; 2004 Dec; 40(6):1199-207. PubMed ID: 15622375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of neointimal hyperplasia in rats treated with atorvastatin after carotid artery injury may be mainly associated with down-regulation of survivin and Fas expression.
    Xu Y; Zhou S; Fang Z; Li X; Huang D; Liu Q; Zheng C
    Pharm Biol; 2014 Sep; 52(9):1196-203. PubMed ID: 25116077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of Rho-associated kinase in differential regulation by statins of interleukin-1beta- and lipopolysaccharide-mediated nuclear factor kappaB activation and inducible nitric-oxide synthase gene expression in vascular smooth muscle cells.
    Wei CY; Huang KC; Chou YH; Hsieh PF; Lin KH; Lin WW
    Mol Pharmacol; 2006 Mar; 69(3):960-7. PubMed ID: 16317111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.